Amisulpride is an antiemetic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; what does it look like in practice? Can it work as a ‘rescue therapy’? What does the data tell us? Could a treatment for post-operative nausea and vomiting be a way to really enhance value based care and enhanced recovery?
Supported in part through an unrestricted educational grant from Acacia Pharma, Inc.
Presented by Desiree Chappell and Monty Mythen with their guest Dru Riddle, Associate Professor of Professional Practice in the School of Nurse Anesthesia at Texas Christian University, Associate Professor of Medical Education, TCU School of Medicine, and Director of the Center for Translational Research: A JBI Center of Excellence and Cochrane US TCU Center.